Peter ten Haaft

1.8k total citations
43 papers, 1.3k citations indexed

About

Peter ten Haaft is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Peter ten Haaft has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Virology, 23 papers in Epidemiology and 22 papers in Infectious Diseases. Recurrent topics in Peter ten Haaft's work include HIV Research and Treatment (42 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (12 papers). Peter ten Haaft is often cited by papers focused on HIV Research and Treatment (42 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (12 papers). Peter ten Haaft collaborates with scholars based in Netherlands, Germany and United States. Peter ten Haaft's co-authors include Jonathan L. Heeney, Klaus Überla, Brigitte Rosenwirth, Babs E. Verstrepen, Christiane Stahl‐Hennig, Henk Niphuis, Gerhard Hunsmann, Ulrike Sauermann, Michael Krawczak and Rob Dubbes and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Journal of Virology.

In The Last Decade

Peter ten Haaft

43 papers receiving 1.2k citations

Peers

Peter ten Haaft
Simoy Goldstein United States
Agneta von Gegerfelt United States
Patricia Polacino United States
Kelli Oswald United States
Harry W. Kestler United States
Florence Buseyne France
Nathan Whizin United States
Henk Niphuis Netherlands
Karen A. Kent United Kingdom
Takeo Kuwata Japan
Simoy Goldstein United States
Peter ten Haaft
Citations per year, relative to Peter ten Haaft Peter ten Haaft (= 1×) peers Simoy Goldstein

Countries citing papers authored by Peter ten Haaft

Since Specialization
Citations

This map shows the geographic impact of Peter ten Haaft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter ten Haaft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter ten Haaft more than expected).

Fields of papers citing papers by Peter ten Haaft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter ten Haaft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter ten Haaft. The network helps show where Peter ten Haaft may publish in the future.

Co-authorship network of co-authors of Peter ten Haaft

This figure shows the co-authorship network connecting the top 25 collaborators of Peter ten Haaft. A scholar is included among the top collaborators of Peter ten Haaft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter ten Haaft. Peter ten Haaft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pöhlmann, Stefan, Jan Münch, Jacqueline D. Reeves, et al.. (2006). A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo. Virology. 360(2). 275–285. 3 indexed citations
3.
Überla, Klaus, Brigitte Rosenwirth, Peter ten Haaft, et al.. (2006). Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV‐infected rhesus monkeys undergoing antiretroviral therapy. Journal of Medical Primatology. 36(1). 2–9. 12 indexed citations
4.
Kuate, Seraphin, Christiane Stahl‐Hennig, Peter ten Haaft, Jonathan L. Heeney, & Klaus Überla. (2003). Single-cycle immunodeficiency viruses provide strategies for uncoupling in vivo expression levels from viral replicative capacity and for mimicking live-attenuated SIV vaccines. Virology. 313(2). 653–662. 26 indexed citations
5.
Stahl‐Hennig, Christiane, Ulf Dittmer, Peter ten Haaft, et al.. (2003). Replication, Immunogenicity, and Protective Properties of Live-Attenuated Simian Immunodeficiency Viruses Expressing Interleukin-4 or Interferon-γ. Virology. 305(2). 473–485. 18 indexed citations
6.
Krawczak, Michael, et al.. (2002). MHC Class I Alleles Influence Set-Point Viral Load and Survival Time in Simian Immunodeficiency Virus-Infected Rhesus Monkeys. The Journal of Immunology. 169(6). 3438–3446. 126 indexed citations
7.
Polyanskaya, Natasha, Lesley A. Bergmeier, Sally Sharpe, et al.. (2001). Mucosal Exposure to Subinfectious Doses of SIV Primes Gut-Associated Antibody-Secreting Cells and T Cells: Lack of Enhancement by Nonneutralizing Antibody. Virology. 279(2). 527–538. 15 indexed citations
8.
Haaft, Peter ten, Neil Almond, Aurelio Cafaro, et al.. (2001). Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection. Journal of Medical Primatology. 30(4). 207–214. 33 indexed citations
9.
Nilsson, Charlotta, Barbro Mäkitalo, Peter Berglund, et al.. (2001). Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara. Vaccine. 19(25-26). 3526–3536. 59 indexed citations
10.
Negri, Donatella, Silvia Baroncelli, Zuleika Michelini, et al.. (2001). Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIVmacJ5 on the kinetics of SIV replication in cynomolgus monkeys. Journal of Medical Primatology. 30(4). 197–206. 10 indexed citations
11.
Zuber, Bartek, D Böttiger, Reinhold Benthin, et al.. (2001). An in Vivo Model for HIV Resistance Development. AIDS Research and Human Retroviruses. 17(7). 631–635. 18 indexed citations
12.
Haaft, Peter ten, Krishna K. Murthy, H M McClure, et al.. (2001). Differences in early virus loads with different phenotypic variants of HIV-1 and SIVcpz in chimpanzees. AIDS. 15(16). 2085–2092. 24 indexed citations
13.
Czub, Stefanie, Ursula G. Sauer, Eleni Koutsilieri, et al.. (2000). Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia with neurological disease in macaques infected with different strains of SIV. Journal of NeuroVirology. 6(3). 187–201. 28 indexed citations
14.
Heeney, Jonathan L., Gerrit Koopman, Brigitte Rosenwirth, et al.. (2000). A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens. Journal of Medical Primatology. 29(3-4). 268–273. 15 indexed citations
15.
Cafaro, Aurelio, Antonella Caputo, Maria Teresa Maggiorella, et al.. (2000). SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine. Journal of Medical Primatology. 29(3-4). 193–208. 44 indexed citations
16.
Carl, Silke, A. John Iafrate, Sabine M. Lang, et al.. (1999). The Acidic Region and Conserved Putative Protein Kinase C Phosphorylation Site in Nef Are Important for SIV Replication in Rhesus Macaques. Virology. 257(1). 138–155. 14 indexed citations
17.
Bogers, Willy, Rob Dubbes, Peter ten Haaft, et al.. (1997). Comparison ofin Vitroandin VivoInfectivity of Different Clade B HIV-1 Envelope Chimeric Simian/Human Immunodeficiency Viruses inMacaca mulatta. Virology. 236(1). 110–117. 21 indexed citations
18.
Heeney, Jonathan L., Willy Bogers, Rob Dubbes, et al.. (1996). Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS. Immunology Letters. 51(1-2). 45–52. 24 indexed citations
19.
Haaft, Peter ten, Marion Cornelissen, Jaap Goudsmit, et al.. (1995). Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination. Journal of General Virology. 76(4). 1015–1020. 25 indexed citations
20.
Vries, Petra de, Jonathan L. Heeney, Jolande Boes, et al.. (1994). Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines. Vaccine. 12(15). 1443–1452. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simoy Goldstein Breakdown of academic impact, for papers by Agneta von Gegerfelt Breakdown of academic impact, for papers by Patricia Polacino Breakdown of academic impact, for papers by Kelli Oswald Breakdown of academic impact, for papers by Harry W. Kestler Breakdown of academic impact, for papers by Florence Buseyne Breakdown of academic impact, for papers by Nathan Whizin Breakdown of academic impact, for papers by Henk Niphuis Breakdown of academic impact, for papers by Karen A. Kent Breakdown of academic impact, for papers by Takeo Kuwata
Rankless by CCL
2026